Personal information

Other IDs

SciProfiles: 1482861
Scopus Author ID: 57217180753

Activities

Collapse all

Employment (2)

University of Insubria: Varese, IT

2024-05-01 to present | Postdoctoral Researcher (Science and High Technology )
Employment
Source: Self-asserted source
Giulia Cazzaniga

University of Milan: Milano, Lombardia, IT

2020-10-01 to present | Dottorandi
Employment
Source: check_circle
Università degli Studi di Milano - IRIS

Education and qualifications (2)

University of Milan: Milan, IT

2020-10 to 2024-02 | PhD in Pharmaceutical Sciences
Education
Source: Self-asserted source
Giulia Cazzaniga

University of Milan: Milan, IT

2014-09 to 2020-03 | Master degree in Pharmaceutical Chemistry and Technology
Education
Source: Self-asserted source
Giulia Cazzaniga

Works (34)

Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy

2025-01-01 | Journal article
DOI: 10.1021/acs.jmedchem.4c02386
HANDLE: 2434/1151479
PMID: 40029993
Source: check_circle
Università degli Studi di Milano - IRIS

Anti-biofilm efficacy of novel silica-based nanoparticles functionalized with natural derivatives for surface coating

Materials Today Chemistry
2024-12 | Journal article
DOI: 10.1016/j.mtchem.2024.102375
Contributors: Giulia Cazzaniga; Cristina Cattò; Matteo Mori; Patricia Hayes; Dan Yang; Nuwan H. Arachchi; Federica Villa; Francesca Cappitelli; Alice Melocchi; Lucia Zema et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Exploring the Inhibition of Iron Acquisition in M. abscessus as a Potential Anti-Virulence Strategy in People with Cystic Fibrosis

2024-08-28 | Other
HANDLE: 2434/1095128
Source: check_circle
Università degli Studi di Milano - IRIS

Synthesis and Analytical Characterization of Cyclization Products of 3-Propargyloxy-5-benzyloxy-benzoic Acid Methyl Ester

Molbank
2024-04-16 | Journal article
DOI: 10.3390/M1806
Contributors: Matteo Mori; Giulia Cazzaniga; Donatella Nava; Elena Pini
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Towards a safe treatment of Insulin Resistance: γ-hydroxy lactone-based derivatives as PPARγ non-agonists

2024-04-09 | Other
HANDLE: 2434/1047194
Source: check_circle
Università degli Studi di Milano - IRIS

Targeting iron acquisition in M. abscessus: a new strategy for the development of anti-virulence agents for cystic fibrosis patients

2024-03-07 | Other
HANDLE: 2434/1048612
Source: check_circle
Università degli Studi di Milano - IRIS

Eco‐Friendly Bio‐Based Solvents for the Acetylation of the Amino Group of Amino Acids

Chemistry & Biodiversity
2024-02 | Journal article
DOI: 10.1002/cbdv.202301729
Contributors: Giulia Cazzaniga; Andrea Tresoldi; Arianna Gelain; Fiorella Meneghetti; Matteo Mori; Stefania Villa
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Γ-HYDROXY LACTONE AS A VERSATILE SCAFFOLD FOR THE DEVELOPMENT OF NOVEL BIOACTIVE COMPOUNDS

2024-02-13 | Other
HANDLE: 2434/1026878
Source: check_circle
Università degli Studi di Milano - IRIS

Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus

2024-02-05 | Journal article
DOI: 10.1016/j.ejmech.2023.116073
HANDLE: 2434/1023181
EID:

2-s2.0-85181702111

PMID: 38169270
WOSUID:

WOS:001156217500001
Source: check_circle
Università degli Studi di Milano - IRIS

Ironing out Fe3+ acquisition in M. abscessus: a new strategy to target virulence factors in non-tuberculous mycobacteria

2023-11-14 | Other
HANDLE: 2434/1023597
Source: check_circle
Università degli Studi di Milano - IRIS

Discovery of novel SIRT5 activators as potential anti-inflammatory agents

2023-11-01 | Other
HANDLE: 2434/1023674
Source: check_circle
Università degli Studi di Milano - IRIS

Optimizing the drug discovery process for the development of MbtI inhibitors as promising anti-virulence agents against TB

2023-09-21 | Other
HANDLE: 2434/1023594
Source: check_circle
Università degli Studi di Milano - IRIS

γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS

2023-07-22 | Other
HANDLE: 2434/1004310
Source: check_circle
Università degli Studi di Milano - IRIS

γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS.

2023-07-19 | Other
HANDLE: 2434/1004309
Source: check_circle
Università degli Studi di Milano - IRIS

γ-hidroxy-lactone derivatives as ppar-γ non-agonists blocking cdk5-mediated phosporylation for a safer anti-diabetic treatment

2023-07-05 | Other
HANDLE: 2434/1004228
Source: check_circle
Università degli Studi di Milano - IRIS

Biological Screening and Crystallographic Studies of Hydroxy γ-Lactone Derivatives to Investigate PPARγ Phosphorylation Inhibition

Biomolecules
2023-04-19 | Journal article
DOI: 10.3390/biom13040694
Contributors: Davide Capelli; Giulia Cazzaniga; Matteo Mori; Antonio Laghezza; Fulvio Loiodice; Martina Quaglia; Elisa Negro; Fiorella Meneghetti; Stefania Villa; Roberta Montanari
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria

2023-02-02 | Journal article
DOI:

10.3390/ pharmaceutics15020502

HANDLE: 2434/953166
EID:

2-s2.0-85149137345

WOSUID:

WOS:000941682300001
Source: check_circle
Università degli Studi di Milano - IRIS

Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria

Pharmaceutics
2023-02-02 | Journal article
DOI: 10.3390/pharmaceutics15020502
Contributors: Matteo Mori; Giovanni Stelitano; Giulia Cazzaniga; Arianna Gelain; Andrea Tresoldi; Mario Cocorullo; Martina Roversi; Laurent R. Chiarelli; Martina Tomaiuolo; Pietro Delre et al.
Source: check_circle
Crossref

5-(4-Nitrophenyl)furan-2-carboxylic Acid

Molbank
2022-12-02 | Journal article
DOI: 10.3390/M1515
Contributors: Matteo Mori; Andrea Tresoldi; Stefania Villa; Giulia Cazzaniga; Marco Bellinzoni; Fiorella Meneghetti
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Development of a novel approach to overcome biofilm formation by natural product derivatives

2022-11-24 | Other
HANDLE: 2434/947059
Source: check_circle
Università degli Studi di Milano - IRIS

Polymersomes as selective drug delivery carriers for innovative anti-TB agents

2022-11-21 | Other
HANDLE: 2434/961660
Source: check_circle
Università degli Studi di Milano - IRIS

Methyl 5-(2-Fluoro-4-nitrophenyl)furan-2-carboxylate

Molbank
2022-11-12 | Journal article
DOI: 10.3390/M1492
Contributors: Matteo Mori; Andrea Tresoldi; Giulia Cazzaniga; Fiorella Meneghetti; Stefania Villa
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Phagocyte-targeting polymersomes as intracellular delivery carriers for enzymatic inhibitors with antitubercular activity

2022-10-24 | Other
HANDLE: 2434/961679
Source: check_circle
Università degli Studi di Milano - IRIS

New strategies to overcome biofilm formation by natural product derivatives

2022-09-13 | Other
HANDLE: 2434/960043
Source: check_circle
Università degli Studi di Milano - IRIS

Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections

Pharmaceuticals
2022-08-11 | Journal article
DOI: 10.3390/ph15080992
Contributors: Matteo Mori; Giovanni Stelitano; Anna Griego; Laurent R. Chiarelli; Giulia Cazzaniga; Arianna Gelain; Elena Pini; Marina Camera; Paola Canzano; Andrea Fumagalli et al.
Source: check_circle
Crossref
grade
Preferred source (of 4)‎

Insights on the Modulation of SIRT5 Activity: A Challenging Balance

Molecules
2022-07-12 | Journal article
DOI: 10.3390/molecules27144449
Contributors: Matteo Mori; Giulia Cazzaniga; Fiorella Meneghetti; Stefania Villa; Arianna Gelain
Source: check_circle
Crossref
grade
Preferred source (of 4)‎

γ-lactone derivatives: a new promising class of protein tyrosine phosphatase B (MptpB) inhibitors as anti-TB agents

2022-07-03 | Other
HANDLE: 2434/961665
Source: check_circle
Università degli Studi di Milano - IRIS

Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent

European Journal of Medicinal Chemistry
2022-04 | Journal article
DOI: 10.1016/j.ejmech.2022.114235
Contributors: Giulia Cazzaniga; Matteo Mori; Fiorella Meneghetti; Laurent R. Chiarelli; Giovanni Stelitano; Isabella Caligiuri; Flavio Rizzolio; Samuele Ciceri; Giulio Poli; Diana Staver et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Native llama Nanobody Library Panning Performed by Phage and Yeast Display Provides Binders Suitable for C-Reactive Protein Detection

Biosensors
2021-12-03 | Journal article
DOI: 10.3390/bios11120496
Contributors: Sandra Oloketuyi; Robert Bernedo; Andreas Christmann; Justyna Borkowska; Giulia Cazzaniga; Horst Wilhelm Schuchmann; Joanna Niedziółka-Jönsson; Katarzyna Szot-Karpińska; Harald Kolmar; Ario de Marco
Source: check_circle
Crossref
grade
Preferred source (of 4)‎

Natural products against key Mycobacterium tuberculosis enzymatic targets: Emerging opportunities for drug discovery

European Journal of Medicinal Chemistry
2021-11 | Journal article
DOI: 10.1016/j.ejmech.2021.113732
Contributors: Giulia Cazzaniga; Matteo Mori; Laurent Roberto Chiarelli; Arianna Gelain; Fiorella Meneghetti; Stefania Villa
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Unraveling the interaction mechanism of a benzothiadiazole-2.2-dioxide derivative with STAT3 : towards novel direct inhibitors

2021-09-15 | Other | Author
HANDLE: 2434/876303
Contributors: Matteo Mori; Ettore Gilardoni; Luca Regazzoni; ALESSANDRO PEDRETTI; DIEGO RODOLFO COLOMBO; Parkinson, G.; Asai, A.; Giulia Cazzaniga; FIORELLA MENEGHETTI; Stefania Villa et al.
Source: check_circle
Università degli Studi di Milano - IRIS

Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents

Pharmaceuticals
2021-02 | Journal article | Author
DOI: 10.3390/ph14020155
Contributors: Matteo Mori; Giovanni Stelitano; Laurent Roberto Chiarelli; Giulia Cazzaniga; Arianna Gelain; Daniela Barlocco; Elena Pini; FIORELLA MENEGHETTI; Stefania Villa
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 4)‎

A dual-target approach in anti-tuberculosis therapy: new MptpB/MbtI inhibitors

2020-07-22 | Other
HANDLE: 2434/961662
Source: check_circle
Università degli Studi di Milano - IRIS

6-Hydroxy-2-methylbenzofuran-4-carboxylic acid

2020-06-18 | Journal article
DOI: 10.3390/M1143
HANDLE: 2434/742112
EID:

2-s2.0-85086657220

WOSUID:

WOS:000551575100006
Contributors: Matteo Mori; FIORELLA MENEGHETTI; Chiarelli, L.R.; Alessia, D.; Nava, D.; Arianna Gelain; Cazzaniga, G.; Stefania Villa; Elena Pini
Source: check_circle
Università degli Studi di Milano - IRIS
grade
Preferred source (of 2)‎
How many people are using ORCID?